Scared of needles? Here’s some good news: in the future, you might be able to rub a vaccination into your skin.
Researchers at the University of Auckland have found a way to deliver medicines through skin, which is usually an impervious barrier.
“It’s like wearing a raincoat – it stops the water getting in, we go out in the rain and we don’t melt, stops all those nasty chemicals getting through our skin most of the time,” says Dr Dareen Svirskis, senior pharmacy lecturer.
“This is potentially a breakthrough peptide technology,” says Professor Julia Kennedy, head of Auckland University’s School of Pharmacy. “Obtaining a biological response from applying substances through the skin is very difficult to achieve and approaches can be extremely expensive.”
For the past four years senior pharmacy lecturer Zimei Wu has been supervising research by PhD candidate Travis Badenhorst, with the assistance of Dr Svirskis. Dr Svirskis says their breakthrough allows drugs to be delivered directly to cells through the skin.
“What Zimei’s envisaged is to develop this tiny little nano formulation, these tiny little nano carriers. We can put the peptide inside that, and what’s amazing is that we’ve seen for the first time that it can be delivered to the skin, it’ll pass through the skin and it’ll be taken up in cells.
“We’ve seen this in cell cultures for the first time biologically, and we’ve seen this in human skin as well.”
The research was financially backed by the Government and Auckland-based skincare company Snowberry, which has applied for a patent on the process.
And there’s a good reason a cosmetics company backed the research – Dr Svirskis says the technology is perfect for anti-aging products, and outperformed every existing commercial product they compared it to during testing.
“The cosmetic route’s a lot faster to get a product to people. When we start talking about medical devices or vaccine delivery, then yes, there’s years of testing they have to go through to ensure the safety and efficacy of these products.”
Read more:Â Medical breakthrough threatens to banish needles forever
The Latest on: Peptide technology
[google_news title=”” keyword=”Peptide technology” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Peptide technology
- Entera Bio Reports Q1 2024 Financial Results and Provides Business Updateson May 10, 2024 at 2:00 pm
In April 2024, Entera submitted to the Endocrine Society Annual Meeting (ENDO 2024) pharmacokinetic (PK) and early PD data from a Phase 1 study evaluating an unmodified PTH (1-34) peptide and a new ...
- Computing takes the guesswork out of chemistryon May 6, 2024 at 4:59 pm
The objective of the work was to find better ways to add groups of carbon to amino acids and peptides, which are very common in ... from fundamental research to the creation of applied technology with ...
- Aligned peptide 'noodles' could enable lab-grown biological tissueson May 3, 2024 at 10:18 am
A team of chemists and bioengineers at Rice University and the University of Houston have achieved a significant milestone in their work to create a biomaterial that can be used to grow biological ...
- Global Peptide Therapeutics Industryon May 2, 2024 at 5:21 am
Global Peptide Therapeutics Industry is valued at US$ 38.0 Bn for 2023 & expected to reach US$ 106.0 Bn by 2033 at a CAGR of 10.8% by 2033.
- Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at ...on May 2, 2024 at 3:31 am
Aanastra, Inc., a biopharmaceutical company focused on developing RNA therapeutics leveraging its peptide delivery technology for targeting cancers and ...
- PeptiDream expands peptide discovery collaboration with Novartison May 2, 2024 at 3:00 am
PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company announced an expansion of its peptide discovery collaboration with Swiss-based Novartis Pharma AG. Under the multi-programme ...
- Novartis and PeptiDream expand peptide discovery collaboration in deal worth over $2.8bnon May 2, 2024 at 12:11 am
Novartis and PeptiDream have expanded their peptide discovery collaboration with a new agreement worth over $2.8bn. The multi-programme agreement will see PeptiDream use its proprietary Peptide ...
- Novartis and PeptiDream expand peptide discovery dealon May 1, 2024 at 3:49 am
Novartis and Japanese biopharmaceutical company PeptiDream have expanded their partnership for the discovery of peptides.
- Novartis, Peptidream expand peptide discovery effort in $2.7B dealon April 30, 2024 at 5:00 pm
Under the multi-program agreement, Kawasaki, Japan-based Peptidream will use its peptide discovery platform system technology to identify and optimize novel macrocyclic peptides against targets ...
- Altimmune gets grant for pharmaceutical composition of peptides for HBV treatmenton April 30, 2024 at 5:39 am
Discover Altimmune Inc's groundbreaking patent for a pharmaceutical composition targeting HBV with peptides containing CD8+ and CD4+ T-cell epitopes. Learn about the innovative intracellular delivery ...
via Bing News